Trial intelligence / Profile preview

Experimental Study on Alcohol Use and Behavior in Young Adults

2022-501809-13-01Phase 2Completed

Sponsor
Karolinska Institutet
Start
May 2023
Modality
Recombinant Proteins and Enzymes, Peptides
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of oxytocin in alcohol use disorder (AUD) (2 arms), sponsored by Karolinska Institutet. Primary endpoint: Prosocial behavior. Started May 2023; status: completed.

02

Drugs

oxytocin
03

Conditions

alcohol use disorder (AUD)

Beyond the preview

Go deeper on 2022-501809-13-01.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2022-501809-13-01.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call